New Treatment in Australia: A New Breakthrough for Reducing Body Weight?
Australia is currently observing the arrival of retatrutide, a novel dual GIP and GLP-1 receptor therapy, representing a significant advance in obesity treatment . Early clinical trials have demonstrated impressive results, showing greater efficacy than existing treatments like semaglutide. While